Therapeutics | Fenwick

Experience

Fenwick Represents Stoke Therapeutics in $40M Series A Financing

January 9, 2018

Experience

Fenwick Represents Pionyr in IP Due Diligence of $62M Series B Financing

December 14, 2017

Experience

Fenwick Represents Mavupharma in $20M Series A Financing

December 4, 2017

Experience

Fenwick Represents Loxo Oncology in Collaboration with Bayer

November 17, 2017

Experience

Fenwick Represents AnaptysBio in $205.5M Follow-On Offering

October 12, 2017

Experience

Fenwick Represents Gritstone Oncology in IP Due Diligence of $97.5M Series B Financing

September 6, 2017

Experience

Fenwick Represents Dermira in its $287.5M Convertible Senior Notes Offering

May 15, 2017

Experience

Fenwick Represents Dermira in $135.8M Follow-On Offering

June 12, 2016

Experience

Fenwick Represents Oncothyreon in $50M At-The-Market Offering

June 2, 2016

Experience

Fenwick Represents Oncothyreon in $22M Shelf Takedown

February 11, 2015

Subscribe to Therapeutics